These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20651198)

  • 21. [No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
    Petrik M; Weigel C; Kirsch M; Hosten N
    Rofo; 2005 Sep; 177(9):1242-9. PubMed ID: 16123870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
    Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
    Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
    Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
    Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
    Lencioni R; Fattori R; Morana G; Stacul F
    Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function.
    Becker J; Babb J; Serrano M
    AJR Am J Roentgenol; 2013 Apr; 200(4):822-6. PubMed ID: 23521455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the use of intravenous contrast material truly safe in patients with impaired renal function?
    Cohen MD
    Radiology; 2009 May; 251(2):613; author reply 613-4. PubMed ID: 19401587
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
    Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
    AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
    J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19.
    Kistner A; Tamm C; Svensson AM; Beckman MO; Strand F; Sköld M; Nyrén S
    BMC Nephrol; 2021 Aug; 22(1):297. PubMed ID: 34465289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Acute Kidney Injury Following Contrast-enhanced CT in Hospitalized Pediatric Patients: A Propensity Score Analysis.
    Gilligan LA; Davenport MS; Trout AT; Su W; Zhang B; Goldstein SL; Dillman JR
    Radiology; 2020 Mar; 294(3):548-556. PubMed ID: 31961262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephropathy in critically Ill patients without preexisting renal disease.
    Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R
    Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
    Werner S; Bez C; Hinterleitner C; Horger M
    PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
    Rathsmann P; Jacobs GF; Müller RD
    Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity.
    Sendur MA; Aksoy S; Yaman S; Arik Z; Tugba Kos F; Akinci MB; Civelek B; Yildirim Ozdemir N; Uncu D; Zengin N
    J BUON; 2013; 18(1):274-80. PubMed ID: 23613416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
    Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
    Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
    Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-contrast dose protection protocol for diagnostic computed tomography in patients at high-risk for contrast-induced nephropathy.
    Kidoh M; Nakaura T; Awai K; Matsunaga Y; Tanoue K; Harada K; Uemura S; Yamashita Y
    J Comput Assist Tomogr; 2013; 37(2):289-96. PubMed ID: 23493222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study.
    McDonald JS; McDonald RJ; Williamson EE; Kallmes DF
    Radiology; 2017 Nov; 285(2):414-424. PubMed ID: 28708022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.